Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Dementia and Geriatric Cognitive Disorders
|
June 8, 2002
Relation between plasma homocysteine and Alzheimer's disease
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
April 16, 2005
Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
October 9, 2008
C-reactive protein: vascular risk marker in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Chemistry and Laboratory Medicine
|
October 10, 2008
Plasma homocysteine and vascular disease in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
August 28, 2010
Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
March 22, 2007
Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
July 21, 2007
Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Biochemistry
|
April 6, 2010
Plasma homocysteine--a marker of vascular disease in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
International Journal of Geriatric Psychiatry
|
September 27, 2002
Optimal use of markers for cobalamin and folate status in a psychogeriatric population
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Biochemistry
|
August 9, 2011
C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time
Karin Nilsson, Lars Gustafson, Björn Hultberg
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Dementia and Geriatric Cognitive Disorders
|
June 8, 2002
Relation between plasma homocysteine and Alzheimer's disease
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
April 16, 2005
Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
October 9, 2008
C-reactive protein: vascular risk marker in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Chemistry and Laboratory Medicine
|
October 10, 2008
Plasma homocysteine and vascular disease in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
August 28, 2010
Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
March 22, 2007
Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease
Karin Nilsson, Lars Gustafson, Björn Hultberg
Dementia and Geriatric Cognitive Disorders
|
July 21, 2007
Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Biochemistry
|
April 6, 2010
Plasma homocysteine--a marker of vascular disease in elderly patients with mental illness
Karin Nilsson, Lars Gustafson, Björn Hultberg
International Journal of Geriatric Psychiatry
|
September 27, 2002
Optimal use of markers for cobalamin and folate status in a psychogeriatric population
Karin Nilsson, Lars Gustafson, Björn Hultberg
Clinical Biochemistry
|
August 9, 2011
C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time
Karin Nilsson, Lars Gustafson, Björn Hultberg
Page
of 6